Articles In Academic Journals

Filter

Year	Title
2010	Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.  Vaccine. 2005-10.
2009	Analysis of the potential for HIV-1 Vpr as an anti-cancer agent.  Current HIV research. 144-52.
2008	Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 5896-903.
2007	Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.  Cancer biology & therapy. 1269-75.
2006	Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.  Molecular therapy : the journal of the American Society of Gene Therapy. 647-55.
2006	Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.  Cancer Gene Therapy. 969-74.
2003	Electroporation as a method for the efficient in vivo delivery of therapeutic genes.  DNA and cell biology. 753.